personalised medicine

News

NICE’s track record in cancer drugs: the impact of the CDF and the role of interim funding

AI test could predict best cancer therapies for patients

Researchers at the Institute of Cancer Research (ICR) in London have designed a prototype test that they think could be used to predict which combinations are likely to work in cancer patie

Views & Analysis

The state of personalised medicine In 2019

Herd immunity is nice – but what about me?

Shahrokh Shabahang discusses why we need a personalised approach to COVID-19 immunity testing.

Market Access

A roadmap for adopting New Science

The pandemic’s disruption galvanised the biopharma industry into unprecedented action, demonstrating what’s possible when the global scientific community collaborates in exceptional ways an

News

COSMIC database matches drugs to cancer mutations

The world's largest database of cancer mutations can now be used to link mutations with drug treatments in what promises to be a step forward in precision oncology.

Views & Analysis

Could personalised medicine change treatment for migraine?

The concept of personalised medicine is becoming established in cancer, with an increasing number of drugs targeting specific mutations making it to market.

Oncology

Preparing for the next decade of innovation in immuno-oncolo...

Immuno-oncology has seen some striking clinical advances in the 10 years since the approval of the first therapeutic cancer vaccine, but it’s a field that doesn’t stand still.